Table 2. Adverse events above grade III related to drug treatment.
| First author | Adverse event | Incidence of grade 3 or higher AE (95% CI) |
Risk ratio (95% CI) |
|---|---|---|---|
| Cloughesy TF | Hepatitis | 0.43 (0.30–0.62) | 50.59 (32.01–80.31) |
| Zhao J | Lipase increased | 0.71 (0.51–0.98) | 42.01 (28.37–61.82) |
| Nduom EK | GGT increased | 0.47 (0.30–0.69) | 41.96 (25.27–66.53) |
| Schalper KA | Type 1 diabetes | 0.18 (0.10–0.30) | 41.86 (20.20–84.44) |
| Du Four S | Colitis | 0.47 (0.34–0.65) | 37.90 (25.49–56.49) |
| Jan CI | Increased transaminases | 0.13 (0.05–0.27) | 34.21 (12.46–84.56) |
AE, adverse event; CI, confidence interval; GGT, gamma-glutamyltransferase.